IGC Pharma, Inc. (IGC) Debt by Year
IGC Pharma, Inc. carried $134K in long-term debt against $405K in cash and equivalents at the end of fiscal year 2025. This represents a decrease of 2.2% from the prior fiscal year. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters IGC Pharma, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
IGC Debt & Cash by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2510-KT | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K | FY1210-K | FY1110-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | $134K-2.2% | $137K-2.8% | $141K-2.1% | $144K-47.8% | $276K | $0 | N/A | N/A | $452K-43.6% | $801K+147.4% | $324K | $0 | N/A | N/A | N/A |
| Cash & Equivalents | $405K-66.2% | $1.2M-62.5% | $3.2M-69.4% | $10.5M-28.1% | $14.5M+100.4% | $7.3M-71.7% | $25.6M+1444.6% | $1.7M+208.2% | $538K-63.9% | $1.5M+80.8% | $824K-19.7% | $1.0M-3.6% | $1.1M+89.1% | $563K-64.4% | $1.6M |
IGC Debt & Cash by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q1'2710-Q | Q4'2610-Q | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | N/A | N/A | $131K-2.2% | $132K-2.2% | $133K-2.2% | $134K-2.2% | $134K-2.9% | $135K-2.9% | $136K-2.9% | $137K-2.8% | $138K-2.1% | $139K-2.1% |
| Cash & Equivalents | $331K-27.1% | $207K-48.9% | $900K+91.5% | $1.1M-28.5% | $454K-75.1% | $405K-66.2% | $470K-65.9% | $1.5M-48.9% | $1.8M+5.9% | $1.2M-62.5% | $1.4M-72.1% | $3.0M-54.3% |
What long-term debt means
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date.
More IGC Pharma, Inc. financials
Frequently Asked Questions
What was IGC Pharma, Inc.'s long-term debt in fiscal year 2025?
IGC Pharma, Inc. carried $134K in long-term debt against $405K in cash and equivalents at the end of fiscal year 2025.
How fast is IGC Pharma, Inc.'s long-term debt growing?
IGC Pharma, Inc. (IGC) long-term debt fell by 2.2% year over year, from $137K to $134K in fiscal year 2025.
What does long-term debt mean on a financial statement?
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date. This page lists what IGC Pharma, Inc. (IGC) reported on that line in every period on record.